Andean Precious Metals (APM) Stock Price, News & Analysis

Company Overview

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: C$1.19 to C$1.29
• 50-Day Range: C$1.29 to C$1.29
• 52-Week Range: C$0.57 to C$2.18
• Volume: 225,691 shs
• Average Volume: 159,585 shs
• Market Capitalization: C$135.47 million
• P/E Ratio: 2.55
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/11/2024
• Today: 10/14/2026

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Materials
• Industry: Metals & Mining
• Sub-Industry: Silver
• Current Symbol: CVE:APM
• CIK: N/A
• Web: www.aptorumgroup.com
• Phone: 852 3953 7700
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$0.51
• Trailing P/E Ratio: 2.55
• Forward P/E Ratio: 3.39
• P/E Growth: N/A
• Net Income: C$37.41 million
• Net Margins: 7.57%
• Pretax Margin: N/A
• Return on Equity: 13.59%
• Return on Assets: 4.13%

Debt

• Debt-to-Equity Ratio: 46.56
• Current Ratio: 2.15
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$154.78 million
• Price / Sales: 0.88
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.98 per share
• Price / Book: 1.32

Miscellaneous

• Outstanding Shares: 105,017,131
• Free Float: N/A
• Market Cap: C$135.47 million
• Optionable: N/A
• Beta: 1.22